{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:02:20Z","timestamp":1791414140096,"version":"4.3.3"},"reference-count":45,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T00:00:00Z","timestamp":1613520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100000774","name":"DOD | Defense Threat Reduction Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007496","name":"Biomedical Laboratory Research and Development, VA Office of Research and Development","doi-asserted-by":"publisher","award":["1I01 BX002872"],"award-info":[{"award-number":["1I01 BX002872"]}],"id":[{"id":"10.13039\/100007496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2021,2,17]]},"abstract":"<jats:p>\n                    The Gram-negative bacterial genus\n                    <jats:italic>Burkholderia<\/jats:italic>\n                    includes several hard-to-treat human pathogens: two biothreat species,\n                    <jats:named-content content-type=\"genus-species\">Burkholderia mallei<\/jats:named-content>\n                    (causing glanders) and\n                    <jats:named-content content-type=\"genus-species\">B. pseudomallei<\/jats:named-content>\n                    (causing melioidosis), and the\n                    <jats:named-content content-type=\"genus-species\">B. cepacia<\/jats:named-content>\n                    complex (BCC) and\n                    <jats:named-content content-type=\"genus-species\">B. gladioli<\/jats:named-content>\n                    , which cause chronic lung infections in persons with cystic fibrosis. All\n                    <jats:italic>Burkholderia<\/jats:italic>\n                    spp. possess an Ambler class A Pen \u03b2-lactamase, which confers resistance to \u03b2-lactams.\n                  <\/jats:p>","DOI":"10.1128\/aac.01930-20","type":"journal-article","created":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T09:31:38Z","timestamp":1608024698000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":15,"title":["<i>In Vitro<\/i>\n                    Antibacterial Activity and\n                    <i>In Vivo<\/i>\n                    Efficacy of Sulbactam-Durlobactam against Pathogenic\n                    <i>Burkholderia<\/i>\n                    Species"],"prefix":"10.1128","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9976-7898","authenticated-orcid":true,"given":"Krisztina M.","family":"Papp-Wallace","sequence":"first","affiliation":[{"name":"Research Service, VA Northeast Healthcare System, Cleveland, Ohio, USA"},{"name":"Department of Medicine, Case Western Reserve University, Cleveland, Ohio, USA"},{"name":"Department of Biochemistry, Case Western Reserve University, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2662-6146","authenticated-orcid":true,"given":"Adam B.","family":"Shapiro","sequence":"additional","affiliation":[{"name":"Entasis Therapeutics, Waltham, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Becka","sequence":"additional","affiliation":[{"name":"Research Service, VA Northeast Healthcare System, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise T.","family":"Zeiser","sequence":"additional","affiliation":[{"name":"Research Service, VA Northeast Healthcare System, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"LiPuma","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Michigan Medical School, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas J.","family":"Lane","sequence":"additional","affiliation":[{"name":"Therapeutic Discovery Branch, U.S. Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rekha G.","family":"Panchal","sequence":"additional","affiliation":[{"name":"Therapeutic Discovery Branch, U.S. Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Mueller","sequence":"additional","affiliation":[{"name":"Entasis Therapeutics, Waltham, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"O\u2019Donnell","sequence":"additional","affiliation":[{"name":"Entasis Therapeutics, Waltham, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7110-0493","authenticated-orcid":true,"given":"Alita A.","family":"Miller","sequence":"additional","affiliation":[{"name":"Entasis Therapeutics, Waltham, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1191\/1479972305cd053ra"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.01592"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00006-19"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1398389"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-8-131"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2016.07.003"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2008.09.010"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00037-09"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00946-08"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.4.1639-1641.2005"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01140-18"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2018.06.005"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.458315"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.11.2399"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.000636"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-019-0159-8"},{"key":"e_1_3_3_18_2","unstructured":"Reference deleted."},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.7b00020"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00590-18"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01595-19"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/nmicrobiol.2017.104"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.04808-14"},{"key":"e_1_3_3_24_2","first-page":"37","article-title":"Sulbactam: a \u03b2-lactamase inhibitor","volume":"7","author":"Noguchi JK","year":"1988","unstructured":"Noguchi JK, Gill MA. 1988. Sulbactam: a \u03b2-lactamase inhibitor. Clin Pharm 7:37\u201351.","journal-title":"Clin Pharm"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.33.4.583"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02315-18"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00181-19"},{"key":"e_1_3_3_28_2","unstructured":"Onufrak N Rubino C Ambrose P Isaacs R Srinivasan S O\u2019Donnell J. 2019. Population pharmacokinetic and pharmacokinetic-pharmacodynamic target attainment analyses of ETX2514SUL to support dosing regimens in patients with varying renal function. European Conference on Clinical Microbiology and Infectious Diseases Amsterdam Netherlands poster P1953."},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1205073109"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.7b00113"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2019.01.003"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm527"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/45.6.813"},{"key":"e_1_3_3_34_2","unstructured":"Van Scoy BD Colquhoun J Tandura A FIkes S Chen A Bhavnani SM Ambrose PG O\u2019Donnell JP. 2018. Evaluation of the pharmacokinetics\/pharmacodynamics of the novel \u03b2-lactamase inhibitor ETX2514 in combination with sulbactam against Acinetobacter baumannii ASM Microbe New Orleans Louisiana 18 June 2020 poster 606."},{"key":"e_1_3_3_35_2","first-page":"158","article-title":"In vitro susceptibility of Burkholderia pseudomallei to cefoperazone-sulbactam combination","volume":"52","author":"Koay AS","year":"1997","unstructured":"Koay AS, Rohani MY, Cheong YM. 1997. In vitro susceptibility of Burkholderia pseudomallei to cefoperazone-sulbactam combination. Med J Malaysia 52:158\u2013160.","journal-title":"Med J Malaysia"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0924-8579(03)00109-2"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.9.3165-3173.2000"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.71.7.3917-3927.2005"},{"key":"e_1_3_3_39_2","volume-title":"Performance standards for antimicrobial susceptibility testing","author":"CLSI","year":"2019","unstructured":"CLSI. 2019. Performance standards for antimicrobial susceptibility testing, 29th ed. Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"29"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02073-15"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.485979"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02625-14"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05769-11"},{"key":"e_1_3_3_44_2","volume-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","author":"CLSI","year":"2018","unstructured":"CLSI. 2018. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 11th ed. Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"11"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.47596-0"},{"key":"e_1_3_3_46_2","volume-title":"Guide for the care and use of laboratory animals","author":"National Research Council","year":"2011","unstructured":"National Research Council. 2011. Guide for the care and use of laboratory animals, 8th ed. National Academies Press, Washington, DC.","edition":"8"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01930-20","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01930-20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T16:51:16Z","timestamp":1645462276000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01930-20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,17]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,2,17]]}},"alternative-id":["10.1128\/AAC.01930-20"],"URL":"https:\/\/doi.org\/10.1128\/aac.01930-20","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,17]]},"assertion":[{"value":"2020-09-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01930-20"}}